FLAXENDOL Trademark

Trademark Overview

On Tuesday, January 31, 2023, a trademark application was filed for FLAXENDOL with the United States Patent and Trademark Office. The USPTO has given the FLAXENDOL trademark a serial number of 97774733. The federal status of this trademark filing is REGISTERED as of Tuesday, August 13, 2024. This trademark is owned by IPS Trust. The FLAXENDOL trademark is filed in the Pharmaceutical Products category with the following description:

Analgesics, namely, naproxen sodium; analgesics
flaxendol

General Information

Serial Number97774733
Word MarkFLAXENDOL
Filing DateTuesday, January 31, 2023
Status700 - REGISTERED
Status DateTuesday, August 13, 2024
Registration Number7476368
Registration DateTuesday, August 13, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 25, 2023

Trademark Statements

Goods and ServicesAnalgesics, namely, naproxen sodium; analgesics

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 17, 2023
Primary Code005
First Use Anywhere DateFriday, March 8, 2024
First Use In Commerce DateFriday, March 8, 2024

Trademark Owner History

Party NameIPS Trust
Party Type30 - Original Registrant
Legal Entity Type17 - Trust
AddressArlington, VA 22201
Party NameIPS Trust
Party Type20 - Owner at Publication
Legal Entity Type17 - Trust
AddressArlington, VA 22201
Party NameIPS Trust
Party Type10 - Original Applicant
Legal Entity Type17 - Trust
AddressArlington, VA 22201

Trademark Events

Event DateEvent Description
Friday, March 17, 2023ASSIGNED TO EXAMINER
Friday, February 3, 2023NEW APPLICATION ENTERED
Friday, February 17, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 21, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 21, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, March 21, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 21, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, March 21, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 25, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 20, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 28, 2023SOU EXTENSION 1 FILED
Tuesday, November 28, 2023SOU EXTENSION 1 GRANTED
Wednesday, November 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 28, 2023SOU TEAS EXTENSION RECEIVED
Thursday, May 2, 2024USE AMENDMENT FILED
Thursday, May 2, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, June 4, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 10, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 10, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 13, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, August 13, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 4, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords

flaxendol analgesics sodium namely naproxen